Frontiers in Medicine (May 2022)

The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis

  • Yi-Hsing Chen,
  • Yi-Hsing Chen,
  • Yi-Hsing Chen,
  • Wen-Nan Huang,
  • Wen-Nan Huang,
  • Wen-Nan Huang,
  • Yi-Ming Chen,
  • Yi-Ming Chen,
  • Yi-Ming Chen,
  • Yi-Ming Chen,
  • Kuo-Lung Lai,
  • Kuo-Lung Lai,
  • Tsu-Yi Hsieh,
  • Tsu-Yi Hsieh,
  • Tsu-Yi Hsieh,
  • Tsu-Yi Hsieh,
  • Wei-Ting Hung,
  • Wei-Ting Hung,
  • Wei-Ting Hung,
  • Ching-Tsai Lin,
  • Ching-Tsai Lin,
  • Chih-Wei Tseng,
  • Chih-Wei Tseng,
  • Kuo-Tung Tang,
  • Kuo-Tung Tang,
  • Kuo-Tung Tang,
  • Yin-Yi Chou,
  • Yin-Yi Chou,
  • Yi-Da Wu,
  • Yi-Da Wu,
  • Chin-Yin Huang,
  • Chia-Wei Hsieh,
  • Chia-Wei Hsieh,
  • Chia-Wei Hsieh,
  • Yen-Ju Chen,
  • Yen-Ju Chen,
  • Yen-Ju Chen,
  • Yu-Wan Liao,
  • Yu-Wan Liao,
  • Hsin-Hua Chen,
  • Hsin-Hua Chen,
  • Hsin-Hua Chen,
  • Hsin-Hua Chen,
  • Hsin-Hua Chen,
  • Hsin-Hua Chen,
  • Hsin-Hua Chen

DOI
https://doi.org/10.3389/fmed.2022.856654
Journal volume & issue
Vol. 9

Abstract

Read online

ObjectivesThe Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) has been widely utilized to evaluate disease activity in patients with ankylosing spondylitis (AS) by an arbitrary cut-off of ≥4 to indicate high disease activity and initiate biological therapy. The Ankylosing Spondylitis Disease Activity Score (ASDAS) is a new composite index to assess AS disease activity states that have been defined and validated. ASDAS ≥2.1 was selected as a criterion to start biological therapy. The purpose of this study was to estimate the corresponding BASDAI and ASDAS cut-off in a Taiwanese AS cohort.MethodsFrom November 2016 to October 2018, we assessed the ASDAS and the BASDAI regularly and recorded demographic data for 489 AS patients in Taichung Veterans General hospital (TCVGH) using an electronic patient-reported data system linked to electronic medical records. We used receiver operating characteristic curves with Youden's J statistic to determine the BASDAI values that correspond to ASDAS disease activity cut-offs (i.e., 1.3, 2.1, and 3.5).ResultsIn our population, the best trade-off BASDAI values corresponding to ASDAS -C-reactive protein (CRP) 1.3, 2.1, and 3.5 were 2.1, 3.1, and 3.7, respectively. The optimal BASDAI values corresponding to ASDAS-erythrocyte sedimentation rates 1.3, 2.1, and 3.5 were 2.0, 2.6, and 4.8, respectively.ConclusionWe propose a revised BASDAI cut-off based on our data, as BASDAI scores are commonly used globally. A more reasonable, lower BASDAI cut-off to initiate or change biological therapy will bring us closer to better decisions to treat AS patients.

Keywords